An Observational Study of Coronary Microvascular Disease of China
Recruiting now
Conditions studied: Coronary Microvascular Disease
In brief
Non-obstructive coronary heart disease refers to patients with angina pectoris without significant narrowing of the epicardial vessels. Coronary microvascular disease(CMD) is a kind of non-obstructive coronary heart disease, and its clinical detection rate is increasing, seriously affecting the quality of life of patients, and increasing the risk of cardiovascular adverse events, but its mechanism has not been fully understood. This study will prospectively collect patients who meet the diagnosis of CMD, observe the development and outcome of the disease, and explore its occurrence and development mechanism.
Key facts
- Study ID
- NCT06676137
- Run by
- Henan Institute of Cardiovascular Epidemiology
- People needed
- 500
- Starts
- 2024-11-11
- Expected to finish
- 2029-10-10
- Last updated by the study team
- 2025-08-20
Who can join
Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Angina symptoms
- Objective evidence of myocardial ischemia
- Coronary angiography was normal,irregular tube wall, or stenosis <50%
You may not qualify if…
- People under the age of 18
- Non-cardiogenic chest pain and other heart conditions such as variant angina, cardiomyopathy, myocarditis or valvular heart disease
Where it is running
- Fuwai central China cardiovascular hospotial — Zhengzhou, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.